
Octotide 0.05mg Injection
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Octotide 0.05mg Injection
Sandostatin LAR 0.05mg Injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is contraindicated. Dosage and frequency are determined by your physician. Consistent use maximizes therapeutic effects; discontinue only under medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you're currently using.
Primary Ingredients of Octotide 0.05mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Octotide 0.05mg Injection
Overgrowth of the extremities, carcinoid cancers, and esophageal variceal hemorrhage.
Major Benefits of Octotide 0.05mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Octotide 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Octotide 0.05mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Octotide 0.05mg Injection works:
Octotide 0.05mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication suppresses the activity of several hormones, including growth hormone, and reduces esophageal bleeding via vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Octotide 0.05mg Injection lacks established safety data. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable medication Octotide (0.05mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remains scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of 0.05mg Octotide Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Administration of Octotide 0.05mg Injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, the 0.05mg Octotide injection presents no safety concerns. No alteration of the 0.05mg Octotide injection dosage is advised.
LiverCAUTION
Patients with liver impairment should use Octotide 0.05mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Octotide 0.05mg Injection :
For a missed dose of Octotide 0.05mg Injection, administer the dose as soon as you remember. If your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Octotide 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin analogs |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Actions | Somatostatin receptor ligands |
